Last reviewed · How we verify
QLS1410
At a glance
| Generic name | QLS1410 |
|---|---|
| Sponsor | Qilu Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- QLS1410 in Participants With Uncontrolled Hypertension (PHASE2)
- A Food Effect Study of QLS1410 in Healthy Chinese Adults (PHASE1)
- A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- QLS1410 CI brief — competitive landscape report
- QLS1410 updates RSS · CI watch RSS
- Qilu Pharmaceutical Co., Ltd. portfolio CI